nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—hypertension—obesity	0.295	1	CtDrD
Carvedilol—NPPB—obesity	0.119	0.506	CbGaD
Carvedilol—Propafenone—Benzphetamine—obesity	0.0874	1	CrCrCtD
Carvedilol—ADRB3—obesity	0.0539	0.228	CbGaD
Carvedilol—ADRB1—obesity	0.0244	0.103	CbGaD
Carvedilol—ADRB2—obesity	0.0205	0.0869	CbGaD
Carvedilol—ADRA1B—Phendimetrazine—obesity	0.0196	0.089	CbGbCtD
Carvedilol—CYP2E1—obesity	0.0178	0.0755	CbGaD
Carvedilol—ADRA1A—Phendimetrazine—obesity	0.0155	0.0702	CbGbCtD
Carvedilol—ADRB2—Phenylpropanolamine—obesity	0.0155	0.0702	CbGbCtD
Carvedilol—ADRB1—Phenylpropanolamine—obesity	0.0153	0.0691	CbGbCtD
Carvedilol—ADRA2C—Methamphetamine—obesity	0.0148	0.0672	CbGbCtD
Carvedilol—ADRA2B—Methamphetamine—obesity	0.0141	0.0638	CbGbCtD
Carvedilol—ADRA2A—Benzphetamine—obesity	0.0122	0.0555	CbGbCtD
Carvedilol—ADRA1A—Benzphetamine—obesity	0.0117	0.0532	CbGbCtD
Carvedilol—ADRA2A—Phenylpropanolamine—obesity	0.0117	0.0529	CbGbCtD
Carvedilol—ADRA1A—Phenylpropanolamine—obesity	0.0112	0.0508	CbGbCtD
Carvedilol—ADRA2A—Methamphetamine—obesity	0.00979	0.0444	CbGbCtD
Carvedilol—CYP2E1—Bupropion—obesity	0.00727	0.0329	CbGbCtD
Carvedilol—CYP2E1—Cimetidine—obesity	0.00533	0.0242	CbGbCtD
Carvedilol—CYP1A2—Phentermine—obesity	0.00494	0.0224	CbGbCtD
Carvedilol—CYP1A2—Phenylpropanolamine—obesity	0.00471	0.0214	CbGbCtD
Carvedilol—CYP2C9—Phentermine—obesity	0.00445	0.0202	CbGbCtD
Carvedilol—CYP1A2—Bupropion—obesity	0.0042	0.019	CbGbCtD
Carvedilol—CYP2D6—Phentermine—obesity	0.00407	0.0185	CbGbCtD
Carvedilol—CYP2C9—Bupropion—obesity	0.00379	0.0172	CbGbCtD
Carvedilol—CYP2D6—Bupropion—obesity	0.00346	0.0157	CbGbCtD
Carvedilol—CYP3A4—Sibutramine—obesity	0.00342	0.0155	CbGbCtD
Carvedilol—CYP2D6—Methamphetamine—obesity	0.00325	0.0148	CbGbCtD
Carvedilol—GJA1—ovarian follicle—obesity	0.00325	0.096	CbGeAlD
Carvedilol—CYP1A2—Cimetidine—obesity	0.00308	0.014	CbGbCtD
Carvedilol—VCAM1—tunica intima—obesity	0.00296	0.0875	CbGeAlD
Carvedilol—CYP2C9—Cimetidine—obesity	0.00278	0.0126	CbGbCtD
Carvedilol—ABCB1—Cimetidine—obesity	0.0027	0.0122	CbGbCtD
Carvedilol—CYP3A4—Benzphetamine—obesity	0.00259	0.0117	CbGbCtD
Carvedilol—CYP2D6—Cimetidine—obesity	0.00254	0.0115	CbGbCtD
Carvedilol—CYP3A4—Bupropion—obesity	0.0022	0.00998	CbGbCtD
Carvedilol—ADRB3—brown adipose tissue—obesity	0.00197	0.0581	CbGeAlD
Carvedilol—CYP3A4—Orlistat—obesity	0.00179	0.00813	CbGbCtD
Carvedilol—CYP3A4—Cimetidine—obesity	0.00162	0.00732	CbGbCtD
Carvedilol—CYP3A4—Topiramate—obesity	0.00106	0.00479	CbGbCtD
Carvedilol—HIF1A—hindbrain—obesity	0.000723	0.0214	CbGeAlD
Carvedilol—HIF1A—gall bladder—obesity	0.000714	0.0211	CbGeAlD
Carvedilol—GJA1—hindbrain—obesity	0.000702	0.0208	CbGeAlD
Carvedilol—NPPB—adrenal cortex—obesity	0.00062	0.0183	CbGeAlD
Carvedilol—GJA1—Crotamiton—Diethylpropion—obesity	0.000573	0.348	CbGdCrCtD
Carvedilol—NPPB—cardiovascular system—obesity	0.000566	0.0167	CbGeAlD
Carvedilol—SELE—respiratory system—obesity	0.000499	0.0148	CbGeAlD
Carvedilol—GJA1—Levomilnacipran—Diethylpropion—obesity	0.000487	0.296	CbGdCrCtD
Carvedilol—GJA1—Milnacipran—Diethylpropion—obesity	0.000487	0.296	CbGdCrCtD
Carvedilol—VCAM1—islet of Langerhans—obesity	0.000486	0.0144	CbGeAlD
Carvedilol—HIF1A—islet of Langerhans—obesity	0.000468	0.0138	CbGeAlD
Carvedilol—VCAM1—respiratory system—obesity	0.000459	0.0136	CbGeAlD
Carvedilol—GJA1—islet of Langerhans—obesity	0.000454	0.0134	CbGeAlD
Carvedilol—HIF1A—respiratory system—obesity	0.000442	0.0131	CbGeAlD
Carvedilol—GJA1—respiratory system—obesity	0.000429	0.0127	CbGeAlD
Carvedilol—SELE—adrenal cortex—obesity	0.000419	0.0124	CbGeAlD
Carvedilol—NPPB—endocrine gland—obesity	0.000388	0.0115	CbGeAlD
Carvedilol—VCAM1—adrenal cortex—obesity	0.000385	0.0114	CbGeAlD
Carvedilol—SELE—cardiovascular system—obesity	0.000382	0.0113	CbGeAlD
Carvedilol—NDUFC2—respiratory system—obesity	0.000373	0.011	CbGeAlD
Carvedilol—HIF1A—adrenal cortex—obesity	0.000371	0.011	CbGeAlD
Carvedilol—GJA1—adrenal cortex—obesity	0.00036	0.0106	CbGeAlD
Carvedilol—VEGFA—islet of Langerhans—obesity	0.000358	0.0106	CbGeAlD
Carvedilol—VCAM1—cardiovascular system—obesity	0.000352	0.0104	CbGeAlD
Carvedilol—SELE—pituitary gland—obesity	0.000339	0.01	CbGeAlD
Carvedilol—HIF1A—cardiovascular system—obesity	0.000338	0.01	CbGeAlD
Carvedilol—SELE—adipose tissue—obesity	0.000337	0.00997	CbGeAlD
Carvedilol—GJA1—cardiovascular system—obesity	0.000328	0.00971	CbGeAlD
Carvedilol—SELE—digestive system—obesity	0.000317	0.00939	CbGeAlD
Carvedilol—NDUFC2—adrenal cortex—obesity	0.000313	0.00926	CbGeAlD
Carvedilol—VCAM1—pituitary gland—obesity	0.000311	0.00921	CbGeAlD
Carvedilol—VCAM1—adipose tissue—obesity	0.00031	0.00917	CbGeAlD
Carvedilol—Bopindolol—ADRB3—obesity	0.000306	0.213	CrCbGaD
Carvedilol—SELE—adrenal gland—obesity	0.000302	0.00895	CbGeAlD
Carvedilol—HIF1A—pituitary gland—obesity	0.0003	0.00886	CbGeAlD
Carvedilol—HIF1A—adipose tissue—obesity	0.000298	0.00883	CbGeAlD
Carvedilol—VCAM1—digestive system—obesity	0.000292	0.00864	CbGeAlD
Carvedilol—GJA1—pituitary gland—obesity	0.000291	0.0086	CbGeAlD
Carvedilol—GJA1—adipose tissue—obesity	0.000289	0.00856	CbGeAlD
Carvedilol—NDUFC2—cardiovascular system—obesity	0.000286	0.00845	CbGeAlD
Carvedilol—VEGFA—adrenal cortex—obesity	0.000284	0.0084	CbGeAlD
Carvedilol—HIF1A—digestive system—obesity	0.000281	0.00831	CbGeAlD
Carvedilol—VCAM1—adrenal gland—obesity	0.000278	0.00823	CbGeAlD
Carvedilol—GJA1—digestive system—obesity	0.000273	0.00806	CbGeAlD
Carvedilol—HIF1A—adrenal gland—obesity	0.000268	0.00792	CbGeAlD
Carvedilol—ADRB3—adipose tissue—obesity	0.000265	0.00785	CbGeAlD
Carvedilol—SELE—endocrine gland—obesity	0.000262	0.00776	CbGeAlD
Carvedilol—GJA1—adrenal gland—obesity	0.00026	0.00768	CbGeAlD
Carvedilol—NDUFC2—pituitary gland—obesity	0.000253	0.00748	CbGeAlD
Carvedilol—NDUFC2—adipose tissue—obesity	0.000252	0.00745	CbGeAlD
Carvedilol—VCAM1—endocrine gland—obesity	0.000241	0.00714	CbGeAlD
Carvedilol—NDUFC2—digestive system—obesity	0.000237	0.00702	CbGeAlD
Carvedilol—SELE—liver—obesity	0.000236	0.00699	CbGeAlD
Carvedilol—HIF1A—endocrine gland—obesity	0.000232	0.00687	CbGeAlD
Carvedilol—VEGFA—pituitary gland—obesity	0.00023	0.00679	CbGeAlD
Carvedilol—VEGFA—adipose tissue—obesity	0.000229	0.00676	CbGeAlD
Carvedilol—NDUFC2—adrenal gland—obesity	0.000226	0.00669	CbGeAlD
Carvedilol—GJA1—endocrine gland—obesity	0.000225	0.00666	CbGeAlD
Carvedilol—VCAM1—liver—obesity	0.000218	0.00643	CbGeAlD
Carvedilol—HIF1A—liver—obesity	0.000209	0.00619	CbGeAlD
Carvedilol—ADRA1A—hindbrain—obesity	0.000208	0.00615	CbGeAlD
Carvedilol—VEGFA—adrenal gland—obesity	0.000205	0.00606	CbGeAlD
Carvedilol—GJA1—liver—obesity	0.000203	0.006	CbGeAlD
Carvedilol—NDUFC2—endocrine gland—obesity	0.000196	0.0058	CbGeAlD
Carvedilol—XDH—digestive system—obesity	0.000192	0.00567	CbGeAlD
Carvedilol—NDUFC2—liver—obesity	0.000177	0.00523	CbGeAlD
Carvedilol—VEGFA—liver—obesity	0.00016	0.00474	CbGeAlD
Carvedilol—XDH—endocrine gland—obesity	0.000158	0.00468	CbGeAlD
Carvedilol—Bopindolol—HTR1B—obesity	0.000156	0.109	CrCbGaD
Carvedilol—Bevantolol—ADRB1—obesity	0.000149	0.104	CrCbGaD
Carvedilol—XDH—liver—obesity	0.000143	0.00422	CbGeAlD
Carvedilol—Bopindolol—ADRB1—obesity	0.000138	0.0962	CrCbGaD
Carvedilol—KCNH2—islet of Langerhans—obesity	0.00013	0.00384	CbGeAlD
Carvedilol—Bevantolol—ADRB2—obesity	0.000126	0.0874	CrCbGaD
Carvedilol—ADRB1—cardiovascular system—obesity	0.000123	0.00364	CbGeAlD
Carvedilol—CYP2D6—hindbrain—obesity	0.000122	0.00362	CbGeAlD
Carvedilol—Bopindolol—ADRB2—obesity	0.000116	0.0809	CrCbGaD
Carvedilol—ADRA1D—endocrine gland—obesity	0.000116	0.00344	CbGeAlD
Carvedilol—Propranolol—ADRB3—obesity	0.000115	0.0798	CrCbGaD
Carvedilol—ADRB1—adipose tissue—obesity	0.000108	0.00321	CbGeAlD
Carvedilol—CYP1A2—respiratory system—obesity	0.000105	0.00311	CbGeAlD
Carvedilol—CYP1A1—respiratory system—obesity	0.000104	0.00306	CbGeAlD
Carvedilol—ADRA2A—islet of Langerhans—obesity	0.000102	0.00302	CbGeAlD
Carvedilol—ADRA2C—adrenal cortex—obesity	0.000102	0.003	CbGeAlD
Carvedilol—Tamsulosin—DRD2—obesity	0.000101	0.0703	CrCbGaD
Carvedilol—GJA1—Phenytoin—Benzphetamine—obesity	9.89e-05	0.0601	CbGdCrCtD
Carvedilol—ADRA1A—cardiovascular system—obesity	9.73e-05	0.00288	CbGeAlD
Carvedilol—CYP2E1—respiratory system—obesity	9.45e-05	0.00279	CbGeAlD
Carvedilol—KCNH2—cardiovascular system—obesity	9.39e-05	0.00278	CbGeAlD
Carvedilol—PTGS1—respiratory system—obesity	9.1e-05	0.00269	CbGeAlD
Carvedilol—ADRA1A—adipose tissue—obesity	8.58e-05	0.00254	CbGeAlD
Carvedilol—ADRB1—endocrine gland—obesity	8.44e-05	0.0025	CbGeAlD
Carvedilol—KCNH2—pituitary gland—obesity	8.32e-05	0.00246	CbGeAlD
Carvedilol—ADRA2C—pituitary gland—obesity	8.21e-05	0.00243	CbGeAlD
Carvedilol—ADRA2C—adipose tissue—obesity	8.17e-05	0.00242	CbGeAlD
Carvedilol—ADRA1A—adrenal gland—obesity	7.69e-05	0.00228	CbGeAlD
Carvedilol—CYP2C9—cardiovascular system—obesity	7.63e-05	0.00226	CbGeAlD
Carvedilol—Propafenone—ADRB1—obesity	7.57e-05	0.0527	CrCbGaD
Carvedilol—KCNH2—adrenal gland—obesity	7.43e-05	0.0022	CbGeAlD
Carvedilol—ADRA2C—adrenal gland—obesity	7.33e-05	0.00217	CbGeAlD
Carvedilol—CYP2E1—cardiovascular system—obesity	7.23e-05	0.00214	CbGeAlD
Carvedilol—CYP1A1—adipose tissue—obesity	7e-05	0.00207	CbGeAlD
Carvedilol—PTGS1—cardiovascular system—obesity	6.97e-05	0.00206	CbGeAlD
Carvedilol—CYP1A2—digestive system—obesity	6.68e-05	0.00197	CbGeAlD
Carvedilol—ADRA1A—endocrine gland—obesity	6.67e-05	0.00197	CbGeAlD
Carvedilol—CYP1A1—digestive system—obesity	6.59e-05	0.00195	CbGeAlD
Carvedilol—ADRA2A—pituitary gland—obesity	6.55e-05	0.00194	CbGeAlD
Carvedilol—ADRA2A—adipose tissue—obesity	6.52e-05	0.00193	CbGeAlD
Carvedilol—KCNH2—endocrine gland—obesity	6.44e-05	0.00191	CbGeAlD
Carvedilol—CYP2C9—digestive system—obesity	6.34e-05	0.00187	CbGeAlD
Carvedilol—PTGS1—pituitary gland—obesity	6.17e-05	0.00183	CbGeAlD
Carvedilol—PTGS1—adipose tissue—obesity	6.15e-05	0.00182	CbGeAlD
Carvedilol—ADRA1A—liver—obesity	6.02e-05	0.00178	CbGeAlD
Carvedilol—CYP2E1—digestive system—obesity	6.01e-05	0.00178	CbGeAlD
Carvedilol—Propranolol—HTR1B—obesity	5.86e-05	0.0408	CrCbGaD
Carvedilol—ADRA2A—adrenal gland—obesity	5.85e-05	0.00173	CbGeAlD
Carvedilol—PTGS1—digestive system—obesity	5.79e-05	0.00171	CbGeAlD
Carvedilol—ADRA2C—liver—obesity	5.73e-05	0.0017	CbGeAlD
Carvedilol—CYP2E1—adrenal gland—obesity	5.72e-05	0.00169	CbGeAlD
Carvedilol—ABCB1—islet of Langerhans—obesity	5.7e-05	0.00169	CbGeAlD
Carvedilol—CYP1A2—endocrine gland—obesity	5.52e-05	0.00163	CbGeAlD
Carvedilol—PTGS1—adrenal gland—obesity	5.51e-05	0.00163	CbGeAlD
Carvedilol—CYP1A1—endocrine gland—obesity	5.44e-05	0.00161	CbGeAlD
Carvedilol—ABCB1—respiratory system—obesity	5.38e-05	0.00159	CbGeAlD
Carvedilol—Psychotic disorder—Topiramate—obesity	5.25e-05	0.000868	CcSEcCtD
Carvedilol—CYP2C9—endocrine gland—obesity	5.24e-05	0.00155	CbGeAlD
Carvedilol—Vertigo—Sibutramine—obesity	5.23e-05	0.000866	CcSEcCtD
Carvedilol—Syncope—Sibutramine—obesity	5.22e-05	0.000865	CcSEcCtD
Carvedilol—Convulsion—Orlistat—obesity	5.21e-05	0.000863	CcSEcCtD
Carvedilol—Leukopenia—Sibutramine—obesity	5.21e-05	0.000863	CcSEcCtD
Carvedilol—Propranolol—ADRB1—obesity	5.18e-05	0.0361	CrCbGaD
Carvedilol—Alopecia—Bupropion—obesity	5.15e-05	0.000853	CcSEcCtD
Carvedilol—Palpitations—Sibutramine—obesity	5.15e-05	0.000852	CcSEcCtD
Carvedilol—Chest pain—Orlistat—obesity	5.12e-05	0.000848	CcSEcCtD
Carvedilol—Myalgia—Orlistat—obesity	5.12e-05	0.000848	CcSEcCtD
Carvedilol—Loss of consciousness—Sibutramine—obesity	5.12e-05	0.000847	CcSEcCtD
Carvedilol—Mood swings—Topiramate—obesity	5.09e-05	0.000842	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	5.09e-05	0.000842	CcSEcCtD
Carvedilol—Cough—Sibutramine—obesity	5.08e-05	0.000841	CcSEcCtD
Carvedilol—Malnutrition—Bupropion—obesity	5.08e-05	0.000841	CcSEcCtD
Carvedilol—ADRA2A—endocrine gland—obesity	5.07e-05	0.0015	CbGeAlD
Carvedilol—Discomfort—Orlistat—obesity	5.06e-05	0.000838	CcSEcCtD
Carvedilol—Convulsion—Sibutramine—obesity	5.05e-05	0.000835	CcSEcCtD
Carvedilol—Blood creatinine increased—Topiramate—obesity	5.03e-05	0.000833	CcSEcCtD
Carvedilol—Hypertension—Sibutramine—obesity	5.03e-05	0.000832	CcSEcCtD
Carvedilol—Dry mouth—Orlistat—obesity	5.01e-05	0.00083	CcSEcCtD
Carvedilol—Flatulence—Bupropion—obesity	5e-05	0.000828	CcSEcCtD
Carvedilol—Dehydration—Topiramate—obesity	5e-05	0.000827	CcSEcCtD
Carvedilol—Tension—Bupropion—obesity	4.98e-05	0.000825	CcSEcCtD
Carvedilol—CYP1A2—liver—obesity	4.97e-05	0.00147	CbGeAlD
Carvedilol—CYP2E1—endocrine gland—obesity	4.96e-05	0.00147	CbGeAlD
Carvedilol—Myalgia—Sibutramine—obesity	4.96e-05	0.000821	CcSEcCtD
Carvedilol—Arthralgia—Sibutramine—obesity	4.96e-05	0.000821	CcSEcCtD
Carvedilol—Chest pain—Sibutramine—obesity	4.96e-05	0.000821	CcSEcCtD
Carvedilol—Nervousness—Bupropion—obesity	4.93e-05	0.000816	CcSEcCtD
Carvedilol—Anaphylactic shock—Orlistat—obesity	4.91e-05	0.000813	CcSEcCtD
Carvedilol—Oedema—Orlistat—obesity	4.91e-05	0.000813	CcSEcCtD
Carvedilol—Back pain—Bupropion—obesity	4.91e-05	0.000813	CcSEcCtD
Carvedilol—CYP1A1—liver—obesity	4.91e-05	0.00145	CbGeAlD
Carvedilol—Orthostatic hypotension—Topiramate—obesity	4.91e-05	0.000812	CcSEcCtD
Carvedilol—Discomfort—Sibutramine—obesity	4.9e-05	0.000811	CcSEcCtD
Carvedilol—Hypokalaemia—Topiramate—obesity	4.89e-05	0.000809	CcSEcCtD
Carvedilol—Muscle spasms—Bupropion—obesity	4.88e-05	0.000808	CcSEcCtD
Carvedilol—Infection—Orlistat—obesity	4.88e-05	0.000808	CcSEcCtD
Carvedilol—Dry mouth—Sibutramine—obesity	4.85e-05	0.000803	CcSEcCtD
Carvedilol—Aspartate aminotransferase increased—Topiramate—obesity	4.84e-05	0.000801	CcSEcCtD
Carvedilol—Toxic epidermal necrolysis—Topiramate—obesity	4.84e-05	0.000801	CcSEcCtD
Carvedilol—CYP3A4—digestive system—obesity	4.83e-05	0.00143	CbGeAlD
Carvedilol—Nasopharyngitis—Topiramate—obesity	4.8e-05	0.000795	CcSEcCtD
Carvedilol—Confusional state—Sibutramine—obesity	4.79e-05	0.000793	CcSEcCtD
Carvedilol—Vision blurred—Bupropion—obesity	4.78e-05	0.000792	CcSEcCtD
Carvedilol—PTGS1—endocrine gland—obesity	4.78e-05	0.00141	CbGeAlD
Carvedilol—Skin disorder—Orlistat—obesity	4.77e-05	0.00079	CcSEcCtD
Carvedilol—CYP2D6—digestive system—obesity	4.76e-05	0.00141	CbGeAlD
Carvedilol—Anaphylactic shock—Sibutramine—obesity	4.75e-05	0.000787	CcSEcCtD
Carvedilol—Oedema—Sibutramine—obesity	4.75e-05	0.000787	CcSEcCtD
Carvedilol—Hyperhidrosis—Orlistat—obesity	4.75e-05	0.000786	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Topiramate—obesity	4.74e-05	0.000784	CcSEcCtD
Carvedilol—Infection—Sibutramine—obesity	4.72e-05	0.000782	CcSEcCtD
Carvedilol—CYP2C9—liver—obesity	4.72e-05	0.0014	CbGeAlD
Carvedilol—Ill-defined disorder—Bupropion—obesity	4.71e-05	0.00078	CcSEcCtD
Carvedilol—Anaemia—Bupropion—obesity	4.69e-05	0.000777	CcSEcCtD
Carvedilol—Shock—Sibutramine—obesity	4.68e-05	0.000774	CcSEcCtD
Carvedilol—Thrombocytopenia—Sibutramine—obesity	4.65e-05	0.00077	CcSEcCtD
Carvedilol—Angioedema—Bupropion—obesity	4.64e-05	0.000768	CcSEcCtD
Carvedilol—Tachycardia—Sibutramine—obesity	4.64e-05	0.000768	CcSEcCtD
Carvedilol—Skin disorder—Sibutramine—obesity	4.62e-05	0.000764	CcSEcCtD
Carvedilol—Hyperhidrosis—Sibutramine—obesity	4.59e-05	0.000761	CcSEcCtD
Carvedilol—Malaise—Bupropion—obesity	4.58e-05	0.000758	CcSEcCtD
Carvedilol—Vertigo—Bupropion—obesity	4.56e-05	0.000755	CcSEcCtD
Carvedilol—Syncope—Bupropion—obesity	4.55e-05	0.000754	CcSEcCtD
Carvedilol—Leukopenia—Bupropion—obesity	4.54e-05	0.000752	CcSEcCtD
Carvedilol—Anorexia—Sibutramine—obesity	4.53e-05	0.00075	CcSEcCtD
Carvedilol—Angina pectoris—Topiramate—obesity	4.52e-05	0.000749	CcSEcCtD
Carvedilol—Sweating increased—Topiramate—obesity	4.52e-05	0.000749	CcSEcCtD
Carvedilol—ABCB1—adrenal cortex—obesity	4.52e-05	0.00134	CbGeAlD
Carvedilol—Palpitations—Bupropion—obesity	4.49e-05	0.000743	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Orlistat—obesity	4.47e-05	0.000741	CcSEcCtD
Carvedilol—CYP2E1—liver—obesity	4.47e-05	0.00132	CbGeAlD
Carvedilol—Bronchitis—Topiramate—obesity	4.46e-05	0.000739	CcSEcCtD
Carvedilol—Loss of consciousness—Bupropion—obesity	4.46e-05	0.000739	CcSEcCtD
Carvedilol—Insomnia—Orlistat—obesity	4.44e-05	0.000735	CcSEcCtD
Carvedilol—Hypotension—Sibutramine—obesity	4.44e-05	0.000735	CcSEcCtD
Carvedilol—Cough—Bupropion—obesity	4.43e-05	0.000734	CcSEcCtD
Carvedilol—Paraesthesia—Orlistat—obesity	4.41e-05	0.00073	CcSEcCtD
Carvedilol—Pancytopenia—Topiramate—obesity	4.41e-05	0.00073	CcSEcCtD
Carvedilol—Convulsion—Bupropion—obesity	4.4e-05	0.000728	CcSEcCtD
Carvedilol—Hypertension—Bupropion—obesity	4.38e-05	0.000726	CcSEcCtD
Carvedilol—Propranolol—ADRB2—obesity	4.36e-05	0.0304	CrCbGaD
Carvedilol—Musculoskeletal discomfort—Sibutramine—obesity	4.33e-05	0.000717	CcSEcCtD
Carvedilol—Dyspepsia—Orlistat—obesity	4.32e-05	0.000716	CcSEcCtD
Carvedilol—Arthralgia—Bupropion—obesity	4.32e-05	0.000716	CcSEcCtD
Carvedilol—Chest pain—Bupropion—obesity	4.32e-05	0.000716	CcSEcCtD
Carvedilol—Myalgia—Bupropion—obesity	4.32e-05	0.000716	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Topiramate—obesity	4.31e-05	0.000714	CcSEcCtD
Carvedilol—Insomnia—Sibutramine—obesity	4.3e-05	0.000712	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	4.29e-05	0.000711	CcSEcCtD
Carvedilol—Pollakiuria—Topiramate—obesity	4.29e-05	0.00071	CcSEcCtD
Carvedilol—Erectile dysfunction—Topiramate—obesity	4.28e-05	0.000708	CcSEcCtD
Carvedilol—Discomfort—Bupropion—obesity	4.27e-05	0.000707	CcSEcCtD
Carvedilol—Decreased appetite—Orlistat—obesity	4.27e-05	0.000707	CcSEcCtD
Carvedilol—Paraesthesia—Sibutramine—obesity	4.27e-05	0.000707	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Orlistat—obesity	4.24e-05	0.000702	CcSEcCtD
Carvedilol—Dyspnoea—Sibutramine—obesity	4.24e-05	0.000702	CcSEcCtD
Carvedilol—Photosensitivity reaction—Topiramate—obesity	4.24e-05	0.000702	CcSEcCtD
Carvedilol—Fatigue—Orlistat—obesity	4.23e-05	0.000701	CcSEcCtD
Carvedilol—Dry mouth—Bupropion—obesity	4.23e-05	0.0007	CcSEcCtD
Carvedilol—Somnolence—Sibutramine—obesity	4.23e-05	0.0007	CcSEcCtD
Carvedilol—Weight increased—Topiramate—obesity	4.22e-05	0.000699	CcSEcCtD
Carvedilol—Weight decreased—Topiramate—obesity	4.2e-05	0.000695	CcSEcCtD
Carvedilol—Pain—Orlistat—obesity	4.2e-05	0.000695	CcSEcCtD
Carvedilol—Hyperglycaemia—Topiramate—obesity	4.19e-05	0.000693	CcSEcCtD
Carvedilol—Dyspepsia—Sibutramine—obesity	4.18e-05	0.000693	CcSEcCtD
Carvedilol—Confusional state—Bupropion—obesity	4.18e-05	0.000692	CcSEcCtD
Carvedilol—Pneumonia—Topiramate—obesity	4.16e-05	0.000689	CcSEcCtD
Carvedilol—Anaphylactic shock—Bupropion—obesity	4.14e-05	0.000686	CcSEcCtD
Carvedilol—Oedema—Bupropion—obesity	4.14e-05	0.000686	CcSEcCtD
Carvedilol—Decreased appetite—Sibutramine—obesity	4.13e-05	0.000684	CcSEcCtD
Carvedilol—Depression—Topiramate—obesity	4.13e-05	0.000683	CcSEcCtD
Carvedilol—ABCB1—cardiovascular system—obesity	4.12e-05	0.00122	CbGeAlD
Carvedilol—Infection—Bupropion—obesity	4.12e-05	0.000682	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Topiramate—obesity	4.1e-05	0.000679	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Sibutramine—obesity	4.1e-05	0.000679	CcSEcCtD
Carvedilol—Shock—Bupropion—obesity	4.08e-05	0.000675	CcSEcCtD
Carvedilol—Renal failure—Topiramate—obesity	4.07e-05	0.000674	CcSEcCtD
Carvedilol—Constipation—Sibutramine—obesity	4.06e-05	0.000673	CcSEcCtD
Carvedilol—Pain—Sibutramine—obesity	4.06e-05	0.000673	CcSEcCtD
Carvedilol—Thrombocytopenia—Bupropion—obesity	4.06e-05	0.000672	CcSEcCtD
Carvedilol—Feeling abnormal—Orlistat—obesity	4.05e-05	0.00067	CcSEcCtD
Carvedilol—Tachycardia—Bupropion—obesity	4.04e-05	0.00067	CcSEcCtD
Carvedilol—Skin disorder—Bupropion—obesity	4.02e-05	0.000666	CcSEcCtD
Carvedilol—Urinary tract infection—Topiramate—obesity	4.02e-05	0.000666	CcSEcCtD
Carvedilol—Gastrointestinal pain—Orlistat—obesity	4.02e-05	0.000665	CcSEcCtD
Carvedilol—Hyperhidrosis—Bupropion—obesity	4.01e-05	0.000663	CcSEcCtD
Carvedilol—CYP3A4—endocrine gland—obesity	3.99e-05	0.00118	CbGeAlD
Carvedilol—Anorexia—Bupropion—obesity	3.95e-05	0.000654	CcSEcCtD
Carvedilol—Haematuria—Topiramate—obesity	3.95e-05	0.000653	CcSEcCtD
Carvedilol—CYP2D6—endocrine gland—obesity	3.93e-05	0.00116	CbGeAlD
Carvedilol—Feeling abnormal—Sibutramine—obesity	3.92e-05	0.000648	CcSEcCtD
Carvedilol—Urticaria—Orlistat—obesity	3.9e-05	0.000646	CcSEcCtD
Carvedilol—Gastrointestinal pain—Sibutramine—obesity	3.89e-05	0.000643	CcSEcCtD
Carvedilol—Sinusitis—Topiramate—obesity	3.88e-05	0.000643	CcSEcCtD
Carvedilol—Abdominal pain—Orlistat—obesity	3.88e-05	0.000643	CcSEcCtD
Carvedilol—Body temperature increased—Orlistat—obesity	3.88e-05	0.000643	CcSEcCtD
Carvedilol—Hypotension—Bupropion—obesity	3.87e-05	0.000641	CcSEcCtD
Carvedilol—Bradycardia—Topiramate—obesity	3.78e-05	0.000626	CcSEcCtD
Carvedilol—Urticaria—Sibutramine—obesity	3.78e-05	0.000625	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Bupropion—obesity	3.78e-05	0.000625	CcSEcCtD
Carvedilol—Body temperature increased—Sibutramine—obesity	3.76e-05	0.000622	CcSEcCtD
Carvedilol—Abdominal pain—Sibutramine—obesity	3.76e-05	0.000622	CcSEcCtD
Carvedilol—Insomnia—Bupropion—obesity	3.75e-05	0.00062	CcSEcCtD
Carvedilol—Haemoglobin—Topiramate—obesity	3.73e-05	0.000618	CcSEcCtD
Carvedilol—Rhinitis—Topiramate—obesity	3.73e-05	0.000617	CcSEcCtD
Carvedilol—Paraesthesia—Bupropion—obesity	3.72e-05	0.000616	CcSEcCtD
Carvedilol—Haemorrhage—Topiramate—obesity	3.72e-05	0.000615	CcSEcCtD
Carvedilol—Hypoaesthesia—Topiramate—obesity	3.7e-05	0.000612	CcSEcCtD
Carvedilol—Dyspnoea—Bupropion—obesity	3.69e-05	0.000612	CcSEcCtD
Carvedilol—Pharyngitis—Topiramate—obesity	3.69e-05	0.000611	CcSEcCtD
Carvedilol—Somnolence—Bupropion—obesity	3.68e-05	0.00061	CcSEcCtD
Carvedilol—Urinary tract disorder—Topiramate—obesity	3.67e-05	0.000608	CcSEcCtD
Carvedilol—Oedema peripheral—Topiramate—obesity	3.66e-05	0.000606	CcSEcCtD
Carvedilol—ABCB1—pituitary gland—obesity	3.65e-05	0.00108	CbGeAlD
Carvedilol—Dyspepsia—Bupropion—obesity	3.65e-05	0.000604	CcSEcCtD
Carvedilol—Urethral disorder—Topiramate—obesity	3.64e-05	0.000603	CcSEcCtD
Carvedilol—ABCB1—adipose tissue—obesity	3.63e-05	0.00107	CbGeAlD
Carvedilol—Hypersensitivity—Orlistat—obesity	3.62e-05	0.000599	CcSEcCtD
Carvedilol—Decreased appetite—Bupropion—obesity	3.6e-05	0.000596	CcSEcCtD
Carvedilol—CYP3A4—liver—obesity	3.6e-05	0.00106	CbGeAlD
Carvedilol—Visual impairment—Topiramate—obesity	3.58e-05	0.000593	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Bupropion—obesity	3.58e-05	0.000592	CcSEcCtD
Carvedilol—Fatigue—Bupropion—obesity	3.57e-05	0.000591	CcSEcCtD
Carvedilol—Constipation—Bupropion—obesity	3.54e-05	0.000587	CcSEcCtD
Carvedilol—Pain—Bupropion—obesity	3.54e-05	0.000587	CcSEcCtD
Carvedilol—CYP2D6—liver—obesity	3.54e-05	0.00105	CbGeAlD
Carvedilol—Asthenia—Orlistat—obesity	3.52e-05	0.000583	CcSEcCtD
Carvedilol—Erythema multiforme—Topiramate—obesity	3.51e-05	0.000582	CcSEcCtD
Carvedilol—Hypersensitivity—Sibutramine—obesity	3.5e-05	0.00058	CcSEcCtD
Carvedilol—Pruritus—Orlistat—obesity	3.47e-05	0.000575	CcSEcCtD
Carvedilol—Tinnitus—Topiramate—obesity	3.46e-05	0.000574	CcSEcCtD
Carvedilol—ABCB1—digestive system—obesity	3.42e-05	0.00101	CbGeAlD
Carvedilol—Feeling abnormal—Bupropion—obesity	3.41e-05	0.000565	CcSEcCtD
Carvedilol—Asthenia—Sibutramine—obesity	3.41e-05	0.000565	CcSEcCtD
Carvedilol—Gastrointestinal pain—Bupropion—obesity	3.39e-05	0.000561	CcSEcCtD
Carvedilol—Angiopathy—Topiramate—obesity	3.37e-05	0.000558	CcSEcCtD
Carvedilol—Pruritus—Sibutramine—obesity	3.36e-05	0.000557	CcSEcCtD
Carvedilol—Diarrhoea—Orlistat—obesity	3.36e-05	0.000556	CcSEcCtD
Carvedilol—Immune system disorder—Topiramate—obesity	3.36e-05	0.000556	CcSEcCtD
Carvedilol—Mediastinal disorder—Topiramate—obesity	3.35e-05	0.000554	CcSEcCtD
Carvedilol—Urticaria—Bupropion—obesity	3.29e-05	0.000545	CcSEcCtD
Carvedilol—Alopecia—Topiramate—obesity	3.28e-05	0.000544	CcSEcCtD
Carvedilol—Abdominal pain—Bupropion—obesity	3.28e-05	0.000542	CcSEcCtD
Carvedilol—Body temperature increased—Bupropion—obesity	3.28e-05	0.000542	CcSEcCtD
Carvedilol—ABCB1—adrenal gland—obesity	3.26e-05	0.000964	CbGeAlD
Carvedilol—Diarrhoea—Sibutramine—obesity	3.25e-05	0.000538	CcSEcCtD
Carvedilol—Dizziness—Orlistat—obesity	3.25e-05	0.000538	CcSEcCtD
Carvedilol—Malnutrition—Topiramate—obesity	3.23e-05	0.000536	CcSEcCtD
Carvedilol—Flatulence—Topiramate—obesity	3.19e-05	0.000528	CcSEcCtD
Carvedilol—Tension—Topiramate—obesity	3.17e-05	0.000526	CcSEcCtD
Carvedilol—Dizziness—Sibutramine—obesity	3.14e-05	0.00052	CcSEcCtD
Carvedilol—Nervousness—Topiramate—obesity	3.14e-05	0.00052	CcSEcCtD
Carvedilol—Back pain—Topiramate—obesity	3.13e-05	0.000518	CcSEcCtD
Carvedilol—Vomiting—Orlistat—obesity	3.12e-05	0.000517	CcSEcCtD
Carvedilol—Muscle spasms—Topiramate—obesity	3.11e-05	0.000515	CcSEcCtD
Carvedilol—Rash—Orlistat—obesity	3.1e-05	0.000513	CcSEcCtD
Carvedilol—Dermatitis—Orlistat—obesity	3.09e-05	0.000512	CcSEcCtD
Carvedilol—Headache—Orlistat—obesity	3.08e-05	0.000509	CcSEcCtD
Carvedilol—Hypersensitivity—Bupropion—obesity	3.05e-05	0.000505	CcSEcCtD
Carvedilol—Vision blurred—Topiramate—obesity	3.05e-05	0.000505	CcSEcCtD
Carvedilol—Vomiting—Sibutramine—obesity	3.02e-05	0.0005	CcSEcCtD
Carvedilol—Ill-defined disorder—Topiramate—obesity	3e-05	0.000497	CcSEcCtD
Carvedilol—Rash—Sibutramine—obesity	3e-05	0.000496	CcSEcCtD
Carvedilol—Dermatitis—Sibutramine—obesity	2.99e-05	0.000496	CcSEcCtD
Carvedilol—Anaemia—Topiramate—obesity	2.99e-05	0.000495	CcSEcCtD
Carvedilol—Headache—Sibutramine—obesity	2.98e-05	0.000493	CcSEcCtD
Carvedilol—Asthenia—Bupropion—obesity	2.97e-05	0.000492	CcSEcCtD
Carvedilol—Pruritus—Bupropion—obesity	2.93e-05	0.000485	CcSEcCtD
Carvedilol—Nausea—Orlistat—obesity	2.92e-05	0.000483	CcSEcCtD
Carvedilol—Malaise—Topiramate—obesity	2.92e-05	0.000483	CcSEcCtD
Carvedilol—Vertigo—Topiramate—obesity	2.91e-05	0.000481	CcSEcCtD
Carvedilol—Syncope—Topiramate—obesity	2.9e-05	0.00048	CcSEcCtD
Carvedilol—Leukopenia—Topiramate—obesity	2.9e-05	0.000479	CcSEcCtD
Carvedilol—Palpitations—Topiramate—obesity	2.86e-05	0.000473	CcSEcCtD
Carvedilol—Loss of consciousness—Topiramate—obesity	2.84e-05	0.000471	CcSEcCtD
Carvedilol—Diarrhoea—Bupropion—obesity	2.84e-05	0.000469	CcSEcCtD
Carvedilol—ABCB1—endocrine gland—obesity	2.83e-05	0.000836	CbGeAlD
Carvedilol—Nausea—Sibutramine—obesity	2.82e-05	0.000467	CcSEcCtD
Carvedilol—Cough—Topiramate—obesity	2.82e-05	0.000467	CcSEcCtD
Carvedilol—Convulsion—Topiramate—obesity	2.8e-05	0.000464	CcSEcCtD
Carvedilol—Hypertension—Topiramate—obesity	2.79e-05	0.000462	CcSEcCtD
Carvedilol—Chest pain—Topiramate—obesity	2.75e-05	0.000456	CcSEcCtD
Carvedilol—Myalgia—Topiramate—obesity	2.75e-05	0.000456	CcSEcCtD
Carvedilol—Arthralgia—Topiramate—obesity	2.75e-05	0.000456	CcSEcCtD
Carvedilol—Dizziness—Bupropion—obesity	2.74e-05	0.000454	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	2.73e-05	0.000453	CcSEcCtD
Carvedilol—Discomfort—Topiramate—obesity	2.72e-05	0.00045	CcSEcCtD
Carvedilol—Dry mouth—Topiramate—obesity	2.69e-05	0.000446	CcSEcCtD
Carvedilol—Confusional state—Topiramate—obesity	2.66e-05	0.000441	CcSEcCtD
Carvedilol—Oedema—Topiramate—obesity	2.64e-05	0.000437	CcSEcCtD
Carvedilol—Vomiting—Bupropion—obesity	2.63e-05	0.000436	CcSEcCtD
Carvedilol—Infection—Topiramate—obesity	2.62e-05	0.000434	CcSEcCtD
Carvedilol—Rash—Bupropion—obesity	2.61e-05	0.000433	CcSEcCtD
Carvedilol—Dermatitis—Bupropion—obesity	2.61e-05	0.000432	CcSEcCtD
Carvedilol—Shock—Topiramate—obesity	2.6e-05	0.00043	CcSEcCtD
Carvedilol—Headache—Bupropion—obesity	2.6e-05	0.00043	CcSEcCtD
Carvedilol—Thrombocytopenia—Topiramate—obesity	2.58e-05	0.000428	CcSEcCtD
Carvedilol—Tachycardia—Topiramate—obesity	2.58e-05	0.000427	CcSEcCtD
Carvedilol—Skin disorder—Topiramate—obesity	2.56e-05	0.000425	CcSEcCtD
Carvedilol—Hyperhidrosis—Topiramate—obesity	2.55e-05	0.000423	CcSEcCtD
Carvedilol—ABCB1—liver—obesity	2.55e-05	0.000754	CbGeAlD
Carvedilol—Anorexia—Topiramate—obesity	2.52e-05	0.000417	CcSEcCtD
Carvedilol—Hypotension—Topiramate—obesity	2.47e-05	0.000408	CcSEcCtD
Carvedilol—Nausea—Bupropion—obesity	2.46e-05	0.000407	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Topiramate—obesity	2.41e-05	0.000398	CcSEcCtD
Carvedilol—Insomnia—Topiramate—obesity	2.39e-05	0.000395	CcSEcCtD
Carvedilol—Paraesthesia—Topiramate—obesity	2.37e-05	0.000392	CcSEcCtD
Carvedilol—Dyspnoea—Topiramate—obesity	2.35e-05	0.00039	CcSEcCtD
Carvedilol—Somnolence—Topiramate—obesity	2.35e-05	0.000389	CcSEcCtD
Carvedilol—Dyspepsia—Topiramate—obesity	2.32e-05	0.000385	CcSEcCtD
Carvedilol—Decreased appetite—Topiramate—obesity	2.29e-05	0.00038	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Topiramate—obesity	2.28e-05	0.000377	CcSEcCtD
Carvedilol—Fatigue—Topiramate—obesity	2.28e-05	0.000377	CcSEcCtD
Carvedilol—Pain—Topiramate—obesity	2.26e-05	0.000374	CcSEcCtD
Carvedilol—Constipation—Topiramate—obesity	2.26e-05	0.000374	CcSEcCtD
Carvedilol—Feeling abnormal—Topiramate—obesity	2.18e-05	0.00036	CcSEcCtD
Carvedilol—Gastrointestinal pain—Topiramate—obesity	2.16e-05	0.000357	CcSEcCtD
Carvedilol—Urticaria—Topiramate—obesity	2.1e-05	0.000347	CcSEcCtD
Carvedilol—Abdominal pain—Topiramate—obesity	2.09e-05	0.000346	CcSEcCtD
Carvedilol—Body temperature increased—Topiramate—obesity	2.09e-05	0.000346	CcSEcCtD
Carvedilol—Hypersensitivity—Topiramate—obesity	1.94e-05	0.000322	CcSEcCtD
Carvedilol—Asthenia—Topiramate—obesity	1.89e-05	0.000314	CcSEcCtD
Carvedilol—Pruritus—Topiramate—obesity	1.87e-05	0.000309	CcSEcCtD
Carvedilol—Diarrhoea—Topiramate—obesity	1.81e-05	0.000299	CcSEcCtD
Carvedilol—Dizziness—Topiramate—obesity	1.75e-05	0.000289	CcSEcCtD
Carvedilol—Vomiting—Topiramate—obesity	1.68e-05	0.000278	CcSEcCtD
Carvedilol—Rash—Topiramate—obesity	1.66e-05	0.000276	CcSEcCtD
Carvedilol—Dermatitis—Topiramate—obesity	1.66e-05	0.000275	CcSEcCtD
Carvedilol—Headache—Topiramate—obesity	1.65e-05	0.000274	CcSEcCtD
Carvedilol—Nausea—Topiramate—obesity	1.57e-05	0.00026	CcSEcCtD
Carvedilol—ADRA2C—Signaling Pathways—PIK3CB—obesity	3.81e-07	5.97e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—obesity	3.81e-07	5.97e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—FASN—obesity	3.81e-07	5.96e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—BCHE—obesity	3.79e-07	5.94e-06	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—obesity	3.79e-07	5.93e-06	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	3.79e-07	5.93e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—obesity	3.78e-07	5.92e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AGT—obesity	3.78e-07	5.92e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GNAS—obesity	3.77e-07	5.91e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—obesity	3.76e-07	5.9e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—obesity	3.76e-07	5.89e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MTOR—obesity	3.75e-07	5.88e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PIK3CB—obesity	3.75e-07	5.88e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—obesity	3.75e-07	5.87e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—obesity	3.75e-07	5.87e-06	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—obesity	3.74e-07	5.86e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—obesity	3.74e-07	5.85e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—obesity	3.73e-07	5.84e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—obesity	3.72e-07	5.82e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PIK3CB—obesity	3.7e-07	5.8e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—obesity	3.7e-07	5.8e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—obesity	3.7e-07	5.8e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT2—obesity	3.7e-07	5.79e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOB—obesity	3.69e-07	5.78e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3R1—obesity	3.68e-07	5.77e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—obesity	3.68e-07	5.77e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—obesity	3.68e-07	5.77e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TYK2—obesity	3.68e-07	5.76e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3CD—obesity	3.68e-07	5.76e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARA—obesity	3.68e-07	5.76e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—obesity	3.67e-07	5.75e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAV1—obesity	3.67e-07	5.75e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOA1—obesity	3.66e-07	5.73e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2E1—obesity	3.66e-07	5.73e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RHOA—obesity	3.65e-07	5.71e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARA—obesity	3.65e-07	5.71e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—obesity	3.63e-07	5.69e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NQO1—obesity	3.62e-07	5.67e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PIK3R1—obesity	3.61e-07	5.65e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—obesity	3.61e-07	5.65e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—obesity	3.58e-07	5.61e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AGT—obesity	3.56e-07	5.58e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3CD—obesity	3.55e-07	5.56e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—obesity	3.55e-07	5.56e-06	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—obesity	3.54e-07	5.54e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AGT—obesity	3.53e-07	5.53e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—LPL—obesity	3.53e-07	5.52e-06	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	3.52e-07	5.51e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—obesity	3.51e-07	5.5e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—obesity	3.5e-07	5.49e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—STAT3—obesity	3.49e-07	5.47e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—obesity	3.49e-07	5.47e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—obesity	3.48e-07	5.46e-06	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—obesity	3.48e-07	5.46e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK8—obesity	3.48e-07	5.45e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—obesity	3.47e-07	5.44e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3R1—obesity	3.47e-07	5.44e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—obesity	3.47e-07	5.44e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCG—obesity	3.47e-07	5.43e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC2A4—obesity	3.47e-07	5.43e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—obesity	3.46e-07	5.42e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAV1—obesity	3.46e-07	5.42e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—obesity	3.46e-07	5.41e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK8—obesity	3.45e-07	5.4e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOA1—obesity	3.45e-07	5.4e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—obesity	3.45e-07	5.4e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GPX1—obesity	3.44e-07	5.39e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—obesity	3.44e-07	5.39e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—PIK3CA—obesity	3.44e-07	5.39e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—obesity	3.43e-07	5.37e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAV1—obesity	3.43e-07	5.37e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYCS—obesity	3.42e-07	5.36e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOA1—obesity	3.42e-07	5.36e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TYK2—obesity	3.42e-07	5.35e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK8—obesity	3.41e-07	5.33e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3CB—obesity	3.4e-07	5.33e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—obesity	3.4e-07	5.32e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RHOA—obesity	3.39e-07	5.31e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—obesity	3.37e-07	5.28e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GGT1—obesity	3.36e-07	5.26e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GOT1—obesity	3.36e-07	5.26e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—obesity	3.35e-07	5.25e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3R1—obesity	3.35e-07	5.25e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CD36—obesity	3.35e-07	5.25e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3CG—obesity	3.34e-07	5.23e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MTOR—obesity	3.33e-07	5.22e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PIK3CB—obesity	3.33e-07	5.22e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—obesity	3.31e-07	5.19e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NCOA1—obesity	3.31e-07	5.18e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.27e-07	5.13e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—obesity	3.26e-07	5.11e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—STK11—obesity	3.26e-07	5.11e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP19A1—obesity	3.26e-07	5.11e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MYC—obesity	3.25e-07	5.08e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—obesity	3.24e-07	5.07e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—obesity	3.23e-07	5.05e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK8—obesity	3.22e-07	5.05e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—obesity	3.21e-07	5.03e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3CB—obesity	3.21e-07	5.02e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—PIK3CA—obesity	3.2e-07	5e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—STAT3—obesity	3.18e-07	4.99e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—POMC—obesity	3.18e-07	4.98e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—obesity	3.18e-07	4.98e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—obesity	3.18e-07	4.97e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK8—obesity	3.17e-07	4.97e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—obesity	3.16e-07	4.95e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—obesity	3.16e-07	4.95e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—STAT3—obesity	3.15e-07	4.94e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3CG—obesity	3.15e-07	4.93e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3CG—obesity	3.12e-07	4.89e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARA—obesity	3.12e-07	4.88e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—STAT3—obesity	3.11e-07	4.88e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MTOR—obesity	3.1e-07	4.85e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3CB—obesity	3.1e-07	4.85e-06	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—obesity	3.09e-07	4.85e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—obesity	3.05e-07	4.77e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—obesity	3.04e-07	4.76e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—COMT—obesity	3.03e-07	4.75e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AGT—obesity	3.02e-07	4.73e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—obesity	3.01e-07	4.72e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—POMC—obesity	3e-07	4.7e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GNB3—obesity	2.99e-07	4.68e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARGC1A—obesity	2.99e-07	4.68e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—obesity	2.98e-07	4.67e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—obesity	2.98e-07	4.66e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—POMC—obesity	2.97e-07	4.65e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MYC—obesity	2.96e-07	4.63e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—obesity	2.96e-07	4.63e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—obesity	2.96e-07	4.63e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—obesity	2.95e-07	4.62e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—STAT3—obesity	2.95e-07	4.61e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3CD—obesity	2.94e-07	4.6e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MYC—obesity	2.93e-07	4.59e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAV1—obesity	2.93e-07	4.59e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—obesity	2.92e-07	4.58e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOA1—obesity	2.92e-07	4.58e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GNAS—obesity	2.91e-07	4.56e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—obesity	2.9e-07	4.54e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—STAT3—obesity	2.9e-07	4.54e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—obesity	2.9e-07	4.54e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MYC—obesity	2.89e-07	4.53e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—obesity	2.89e-07	4.52e-06	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—obesity	2.87e-07	4.5e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOB—obesity	2.85e-07	4.46e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—obesity	2.83e-07	4.43e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK8—obesity	2.82e-07	4.41e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—obesity	2.81e-07	4.4e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.8e-07	4.38e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PIK3CA—obesity	2.78e-07	4.35e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3R1—obesity	2.77e-07	4.35e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—obesity	2.77e-07	4.35e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PIK3CA—obesity	2.77e-07	4.34e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3CD—obesity	2.77e-07	4.34e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PIK3CA—obesity	2.76e-07	4.32e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3CD—obesity	2.74e-07	4.3e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MYC—obesity	2.74e-07	4.29e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—obesity	2.73e-07	4.28e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—obesity	2.73e-07	4.28e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LPL—obesity	2.72e-07	4.26e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—obesity	2.71e-07	4.24e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MYC—obesity	2.69e-07	4.22e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—obesity	2.69e-07	4.22e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—obesity	2.69e-07	4.21e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3CG—obesity	2.67e-07	4.18e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GPX1—obesity	2.66e-07	4.16e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK8—obesity	2.62e-07	4.1e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3R1—obesity	2.61e-07	4.09e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—obesity	2.61e-07	4.09e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—obesity	2.61e-07	4.09e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3R1—obesity	2.59e-07	4.06e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—obesity	2.59e-07	4.06e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CD36—obesity	2.59e-07	4.05e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—STAT3—obesity	2.58e-07	4.03e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—obesity	2.58e-07	4.03e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3CB—obesity	2.56e-07	4.01e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—POMC—obesity	2.54e-07	3.98e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—obesity	2.54e-07	3.97e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—obesity	2.53e-07	3.96e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PIK3CA—obesity	2.51e-07	3.93e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PIK3CA—obesity	2.49e-07	3.9e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PIK3CA—obesity	2.46e-07	3.85e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—obesity	2.45e-07	3.84e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—obesity	2.44e-07	3.82e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3CB—obesity	2.41e-07	3.78e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARA—obesity	2.4e-07	3.77e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MYC—obesity	2.39e-07	3.75e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—STAT3—obesity	2.39e-07	3.75e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3CB—obesity	2.39e-07	3.75e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—obesity	2.39e-07	3.74e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—obesity	2.39e-07	3.74e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—obesity	2.37e-07	3.71e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3CD—obesity	2.35e-07	3.67e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AGT—obesity	2.33e-07	3.65e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PIK3CA—obesity	2.32e-07	3.64e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—obesity	2.32e-07	3.63e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PIK3CA—obesity	2.29e-07	3.58e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—obesity	2.28e-07	3.57e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—obesity	2.27e-07	3.56e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—obesity	2.27e-07	3.55e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAV1—obesity	2.26e-07	3.54e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PIK3CA—obesity	2.26e-07	3.54e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOA1—obesity	2.26e-07	3.53e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—obesity	2.25e-07	3.53e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MYC—obesity	2.22e-07	3.48e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—obesity	2.22e-07	3.48e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—obesity	2.22e-07	3.47e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3R1—obesity	2.21e-07	3.47e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—obesity	2.21e-07	3.47e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—obesity	2.2e-07	3.45e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—obesity	2.18e-07	3.41e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3CA—obesity	2.07e-07	3.25e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3CG—obesity	2.06e-07	3.22e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—obesity	2.06e-07	3.22e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—obesity	2.05e-07	3.21e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3CB—obesity	2.04e-07	3.2e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—obesity	2.03e-07	3.18e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PIK3CA—obesity	2.03e-07	3.18e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—obesity	2.03e-07	3.17e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—obesity	2.03e-07	3.17e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—obesity	2.01e-07	3.14e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—obesity	1.99e-07	3.11e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—POMC—obesity	1.96e-07	3.07e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3CA—obesity	1.95e-07	3.06e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—obesity	1.95e-07	3.05e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—obesity	1.9e-07	2.97e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.89e-07	2.96e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—obesity	1.87e-07	2.93e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—obesity	1.84e-07	2.89e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3CD—obesity	1.81e-07	2.83e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—obesity	1.8e-07	2.82e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—obesity	1.79e-07	2.8e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3R1—obesity	1.71e-07	2.68e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—obesity	1.71e-07	2.68e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—obesity	1.69e-07	2.65e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—obesity	1.67e-07	2.62e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—obesity	1.66e-07	2.6e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—obesity	1.6e-07	2.5e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3CB—obesity	1.58e-07	2.47e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—obesity	1.56e-07	2.45e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3CA—obesity	1.56e-07	2.45e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—obesity	1.54e-07	2.42e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3CA—obesity	1.47e-07	2.3e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3CA—obesity	1.46e-07	2.28e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—obesity	1.28e-07	2e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3CA—obesity	1.25e-07	1.95e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—obesity	1.2e-07	1.88e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—obesity	1.19e-07	1.87e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—obesity	1.02e-07	1.59e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3CA—obesity	9.62e-08	1.51e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—obesity	7.86e-08	1.23e-06	CbGpPWpGaD
